Abstract
Summary
Successful passive transfer of immunity to Sarcoma I has been achieved with immune serum. The effect of isoantibody on this tumor appears to be qualitatively similar to that reported for other transplantable tumors, and may account for the rejection of Sarcoma I homografts.
Get full access to this article
View all access options for this article.